Lillian Lai Yun Siu is a Canadian oncologist and physician-scientist who researches anticancer drug development. She is a professor of medicine at the University of Toronto and a senior medical oncologist at the Princess Margaret Cancer Centre.
Lillian Siu | |
|---|---|
| Alma mater | University of Toronto |
| Scientific career | |
| Fields | Oncology |
| Institutions | University of Toronto Princess Margaret Cancer Centre |
Life
editSiu earned a M.D. from the University of Toronto Faculty of Medicine.[1] She completed an oncopharmacology fellowship at the Princess Margaret Cancer Centre and a clinical research fellowship in new drug development at the University of Texas Health Science Center at San Antonio.[1]
Siu researches anticancer drug development.[1] She has served as a professor of medicine at the University of Toronto Faculty of Medicine since 2009 and a senior medical oncologist at the Princess Margaret Cancer Centre since 1998.[1][2] Siu is an elected fellow of the American Society of Clinical Oncology (2015), Canadian Academy of Health Sciences (2023), and the American Association for Cancer Research (AACR).[1] She became the editor-in-chief of Cancer Research Communications in 2021.[1] In 2024, Siu was selected as the president-elect of the AACR.[1]
References
edit- ^ a b c d e f g "Lillian Siu Named 2024–2025 AACR President Elect". The ASCO Post. March 19, 2024. Retrieved 2024-03-23.
- ^ "Lillian L Siu | UHN Research". www.uhnresearch.ca. Retrieved 2024-03-23.